Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| InMed Pharmaceuticals Inc. | 49,050 | reported | 19 Dec 2025 | tx 20+541,770−153,600 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Dec 2025 | GRANT_AWARD | InMed Pharmaceuticals Inc. | 35,000 | 0.00 USD | deriv |
| 15 Dec 2025 | EXERCISE | InMed Pharmaceuticals Inc. | 250 | 0.00 USD | deriv |
| 20 Dec 2024 | GRANT_AWARD | InMed Pharmaceuticals Inc. | 6,250 | 0.00 USD | deriv |
| 27 May 2024 | EXERCISE | InMed Pharmaceuticals Inc. | 1,139 | 0.00 USD | deriv |
| 20 Feb 2024 | PURCHASE | InMed Pharmaceuticals Inc. | 41,600 | 0.36 USD | first after silence |
| 23 Dec 2023 | GRANT_AWARD | InMed Pharmaceuticals Inc. | 136,000 | 0.00 USD | deriv |
| 16 May 2023 | EXERCISE | InMed Pharmaceuticals Inc. | 1,818 | 0.00 USD | deriv |
| 08 Mar 2023 | EXERCISE | InMed Pharmaceuticals Inc. | 545 | 0.00 USD | deriv |
| 16 Dec 2022 | GRANT_AWARD | InMed Pharmaceuticals Inc. | 15,000 | 0.00 USD | deriv |
| 14 Nov 2022 | GRANT_AWARD | InMed Pharmaceuticals Inc. | 15,000 | 0.00 USD | deriv |
| 02 Jun 2022 | EXERCISE | InMed Pharmaceuticals Inc. | 13,636 | 0.00 USD | deriv |
| 14 Apr 2022 | PURCHASE | InMed Pharmaceuticals Inc. | 14,160 | 0.89 USD | |
| 13 Apr 2022 | PURCHASE | InMed Pharmaceuticals Inc. | 8,560 | 0.85 USD | |
| 24 Jan 2022 | EXERCISE | InMed Pharmaceuticals Inc. | 60,606 | 0.00 USD | deriv |
| 24 Jan 2022 | EXERCISE | InMed Pharmaceuticals Inc. | 60,606 | 0.00 USD | deriv |
| 18 Oct 2021 | GRANT_AWARD | InMed Pharmaceuticals Inc. | 125,000 | 0.00 USD | deriv |
| 29 Sept 2021 | PURCHASE | InMed Pharmaceuticals Inc. | 8,800 | 1.73 USD | |
| 28 Sept 2021 | PURCHASE | InMed Pharmaceuticals Inc. | 11,400 | 1.75 USD | |
| 16 Dec 2020 | GRANT_AWARD | InMed Pharmaceuticals Inc. | 125,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 20 Feb 2024.